Sigma Healthcare dividend and valuation

SIG · ASX · AUD

Compare Sigma Healthcare
$2.92Change from previous close: +0.69%Absolute change: +$0.02

Close · November 18, 2026

Valuation

Sigma Healthcare paid $0.04 per share in dividends over the last 12 months (yield 1.4%). Last ex-dividend date: September 3, 2026. The P/E ratio is 48.3. The average price target of 16 analysts is $3.15.

Data as of November 17, 2026

Sigma Healthcare compared with similar companies

Sigma Healthcare's P/E (trailing 12 months): 48.3, +72% against the median of a group of 11 similar companies (28.2).

Sigma Healthcare's metrics compared with similar companies
MetricSigma HealthcareMedian25th–75th percentileBand
P/E (trailing 12 months)48.328.220.4 – 36.0High
Forward P/E33.116.413.9 – 21.2High
EV/EBITDA34.014.412.1 – 18.2High
Price/book6.682.902.66 – 3.90High
Price/sales3.090.360.24 – 1.19High
Gross margin18.1%12.5%5.6% – 21.0%Middle
Operating margin9.2%3.0%1.8% – 6.2%High
Net margin6.5%1.7%1.2% – 3.4%High
ROE14.7%11.2%6.9% – 14.1%High
Debt/equity0.400.780.47 – 1.06Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$33.48B
Enterprise value
$35.24B
PEG
4.83
EV/revenue
3.25

Profitability and growth

ROA
7.2%
ROIC
10.2%
Revenue growth (year over year)
31.9%
Earnings growth (year over year)
44.0%

Financial health

Total cash
$131.12M
Total debt
$2.02B
Current ratio
1.67
Quick ratio
1.04
Altman Z-Score
6.97
Piotroski F-Score
5.00

Dividends

Annual dividend per share
$0.04
Dividend yield
1.4%
Payout ratio
66.7%
Ex-dividend date
September 3, 2026

Analysts and estimates

Average price target
$3.15
Median price target
$3.15
High price target
$3.75
Low price target
$2.70
Analysts with a price target
16
Consensus
Buy
Forward EPS
$0.09
EPS estimate, current year
$0.08

Shares and trading

Beta
0.29
Average volume
21.06M
Shares outstanding
11.54B
Float
5.31B
Institutional ownership
11.8%
Insider ownership
53.7%